Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA

van Schaik, 1995, Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis, Neurology, 45, 1570, 10.1212/WNL.45.8.1570 Willison, 1999, Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies, Eur J Neurol, 6, 71, 10.1046/j.1468-1331.1999.610071.x van der Meche, 1992, A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain–Barré syndrome. Dutch Guillain–Barré Study Group, N Engl J Med, 326, 1123, 10.1056/NEJM199204233261705 1994, Treatment of Guillain–Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study, Ann Neurol, 35, 749, 10.1002/ana.410350618 van Koningsveld, 2004, Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain–Barré syndrome: randomised trial, Lancet, 363, 192, 10.1016/S0140-6736(03)15324-X Van Koningsveld, 2002, Infections and course of disease in mild forms of Guillain–Barré syndrome, Neurology, 58, 610, 10.1212/WNL.58.4.610 Asbury, 1990, Assessment of current diagnostic criteria for Guillain–Barré syndrome, Ann Neurol, 27 Suppl., S21, 10.1002/ana.410270707 Ho, 1995, Guillain–Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies, Brain, 118, 597, 10.1093/brain/118.3.597 Brooks, 1994, J. Neurol. Sci., 124 Suppl., 96, 10.1016/0022-510X(94)90191-0 Jacobs, 1996, Campylobacter jejuni infections and anti-GM1 antibodies in Guillain–Barré syndrome, Ann Neurol, 40, 181, 10.1002/ana.410400209 Snedecor, 1967 Marcus, 1990, Measurement and clinical importance of antibodies to glycosphingolipids, Ann Neurol, 27 Suppl., S53, 10.1002/ana.410270714 Mizutamari, 1994, Characterization of anti-ganglioside antibodies present in normal human plasma, J Neuroimmunol, 50, 215, 10.1016/0165-5728(94)90048-5 Deisenhammer, 1996, Affinity of anti-GM1 antibodies in Guillain–Barré syndrome patients, J Neuroimmunol, 66, 85, 10.1016/0165-5728(96)00029-X Kornberg, 1994, The clinical correlates of high-titer IgG anti-GM1 antibodies, Ann Neurol, 35, 234, 10.1002/ana.410350217 van Schaik, 1994, Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg), J Neuroimmunol, 54, 109, 10.1016/0165-5728(94)90237-2 Galeazzi, 2000, Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE, J Rheumatol, 27, 135 Garcia Guijo, 1995, Presence and isotype of anti-ganglioside antibodies in healthy persons, motor neuron disease, peripheral neuropathy, and other diseases of the nervous system, J Neuroimmunol, 56, 27, 10.1016/0165-5728(94)00129-C Willison, 2002, Peripheral neuropathies and anti-glycolipid antibodies, Brain, 125, 2591, 10.1093/brain/awf272 Van Sorge, 2004, Pathogenicity of anti-ganglioside antibodies in the Guillain–Barré syndrome, Autoimmun Rev, 3, 61, 10.1016/S1568-9972(03)00089-2